Qbqv 3 Ways That Rising Rates Affect Your Portfolio
As far as growth investments go, tech stocks tend to be the ones most investors hone in on. At least, that been the case of late.However, the cannabis sector has also proven itself to be an area of focus for i
stanley puodelis nvestors hoping for long-term growth. Unfortunately, pot stocks haven ;t performed quite as well as their tech counterparts during the pandemic. But other catalysts such as expected U.S. Federal cannabis legalization are once again driving cannabis stocks higher.Additionally, in Canada, domestic growth in cannabis sales has started to pick up of late. This has been perhaps the biggest catalyst for domestically-focused Canadian pot stocks. Here are two companies I think investors bullish on cannabis ought to consider in this space right now.Marijuana stocks are getting high on聽growthCanopy Growth TSX:WEED NYSE:CGC and Hexo TSX:HEXO NYSE:HEXO are reaping the benefits of growth in Canadian pot sales to a greater ex
stanley website tent than many of their peers.Why Well
stanley cup , these two c Audo Bombardier, Inc.: Should You Buy the Bailout Hype
For the past eight months,聽Valeant Pharmaceutical International Inc.聽 TSX: VRX NYSE: VRX has been trying to purchase聽Allergan, Inc.聽 NYSE: AGN . It had even raised the price of its original bid to US$200 a share, which is $70 more than where Allergan was when the bid initially started.However, on Monday, it was reported that Allergan had agreed to be acquired by聽Actavis plc聽 NYSE: ACT for US$219 per share, which would price the company at $66 billion. Unfortunately for Valeant, that was just to
stanley water bottle o rich and it聽announced that it was聽bowing out.Is it time to liquidate your position I don ;t think so. The market has already taken into consideration that the acquisition might never happen. When Valeant and fund manager Bill Ackman announce
stanley thermobecher d their intention to merge Valeant and Alle
stanley quencher rgan on April 22, 2014, the price of Valeant was $149.38. At the close of business on Monday, the price of Valeant was $154.40, which was 1.93% higher than the previous day, despite the failed acquisition.Th
